5-Bromo-2-Hydroxy Pyridyl Hydrazone Two-Component Synthesis

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

There is a need for new therapeutically active agents for treating diseases such as cancer and microbial infections, and existing methods face challenges in synthesizing these compounds efficiently with high yields without using solvents and achieving desired therapeutic activities.

Innovation Solution

The synthesis of 5-bromo-2-hydroxy-N′-[(1E)-1-(pyridin-2-yl)ethylidene]benzohydrazide is achieved through a two-component reaction between methyl-5-bromosalicylic hydrazide in methanol and 2-acetylpyridine in a mixture of acetonitrile and methanol, yielding the compound in exceptional yields (about 82%) for use as an anti-cancer and antimicrobial agent.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If new therapeutically active agents are designed for treating cancer and microbial infections, then therapeutic effectiveness is improved, but synthesis difficulty increases

Engineering Contradiction:
Improvetherapeutic effectivenessVSAvoidsynthesis difficulty
Core Design Contradiction:
ReliabilityVSEase of manufacture

Solution Approach 1:

The synthesis is divided into a two-component reaction system where methyl-5-bromosalicylic hydrazide and 2-acetylpyridine react separately in different solvent systems (methanol and acetonitrile/methanol mixture), which are then combined. This segmentation allows each component to be prepared and optimized independently, reducing overall synthesis difficulty while maintaining therapeutic effectiveness.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

Solvents (methanol and acetonitrile) are used as intermediaries to facilitate the reaction between the two components. The solvent system acts as a mediator that enables the chemical transformation while allowing for easy separation and purification of the final product, thus reducing synthesis difficulty without compromising the therapeutic agent's effectiveness.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Productivity

If synthesis methods are optimized for high yield, then productivity is improved, but process complexity increases

Engineering Contradiction:
Improvesynthesis yieldVSAvoidprocess complexity
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The synthesis achieves high yield (82%) by optimizing specific parameters including the choice of solvents (methanol and acetonitrile mixture), temperature control, and stoichiometric ratios of reactants. These parameter changes are implemented in a straightforward two-step process that maintains simplicity while maximizing productivity through careful control of reaction conditions.

Inventive Principle:
Principle #35Parameter changes

3Ease of operation

If conventional synthesis methods are used, then ease of operation is maintained, but environmental impact worsens due to solvent use

Engineering Contradiction:
Improveease of synthesisVSAvoidsolvent waste
Core Design Contradiction:
Ease of operationVSObject-generated harmful factors

Solution Approach 1:

The reaction employs conventional solvents (methanol and acetonitrile) that can be easily removed by evaporation and potentially recovered through distillation. The filtration step allows for separation of the solid product from the solvent system, enabling solvent recovery and reducing environmental impact while maintaining ease of operation through standard laboratory techniques.

Inventive Principle:
Principle #34Discarding and recovering

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The compound demonstrates high efficiency in treating cancer and microbial infections, showing significant antiproliferative effects on liver and lung cancer cell lines and effective inhibition against various bacterial and fungal strains.

Implementation Method 1

The synthesis of 5-bromo-2-hydroxy-N'-[(1E)-1-(pyridin-2-yl)ethylidene]benzohydrazide is achieved through a two-component reaction between methyl-5-bromosalicylic hydrazide in methanol and 2-acetylpyridine in a mixture of acetonitrile and methanol

Methodology Applied
Scientific EffectCondensation reaction: Chemical Bonding

Data Source

PatentUS20250282726A15-bromo-2-hydroxy-n'-[(1E)-1-(pyridin-2-yl) ethylidene]benzohydrazide as an Anti-cancer and antimicrobial agent
Publication Date: 2025.09.11 KING SAUD UNIVERSITY
  • US20250282726A1 patent drawing
  • US20250282726A1 patent drawing
  • US20250282726A1 patent drawing

AI summary

A 5-bromo-2-hydroxy-N′-[(1E)-1-(pyridin-2-yl)ethylidene]benzohydrazide compound, its synthesis, and its use as an anticancer and an antimicrobial agent.